Status:
RECRUITING
Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Sickle Cell Disease
Vaso-occlusive Pain Episode in Sickle Cell Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.
Detailed Description
A prospective, non-blinded, non-randomized trial will be conducted at the Adult Emergency Department at the University of Maryland Medical Center and Adult Urgent Care Center, which is managed by the ...
Eligibility Criteria
Inclusion
- Adult (age \> 18 years) emergency department patient
- History of sickle cell disease
- Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis
Exclusion
- Prior enrollment in this study
- Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
- Not being treated with intravenous opioids for the vaso-occlusive crisis
- Patients who lack the capacity to provide informed consent
- Medical history of seizures or known intolerance to virtual reality
- Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device.
- Known to be pregnant
- Incarcerated at the time of evaluation
- Over the age of 89 years old
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06184126
Start Date
November 1 2024
End Date
December 31 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Medical Systems
Baltimore, Maryland, United States, 21201